Metropolitan Life Insurance CO Y M Abs Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.83 - $5.11 $673 - $1,216	-238 Reduced 10.38%	2,055 $10,000
Q4 2022 Jun 14, 2023	BUY	$3.0 - $15.17 $714 - $3,610	238 Added 11.58%	2,293 $11.2 Million
Q4 2022 Mar 30, 2023	SELL	$3.0 - $15.17 $36 - $182	-12 Reduced 0.52%	2,293 $11,000
Q4 2022 Feb 15, 2023	SELL	$3.0 - $15.17 $36 - $182	-12 Reduced 0.52%	2,293 $11,000
Q3 2022 Jun 14, 2023	BUY	$13.96 - $19.67 $3,490 - $4,917	250 Added 12.17%	2,305 $33.2 Million
Q2 2022 Jun 20, 2023	BUY	$8.22 - $15.13 $2,055 - $3,782	250 Added 12.17%	2,305 $34,000
Q1 2022 Jun 20, 2023	BUY	$6.55 - $17.42 $1,637 - $4,355	250 Added 12.17%	2,305 $27,000
Q1 2022 Mar 30, 2023	SELL	$6.55 - $17.42 $47,605 - $126,608	-7,268 Reduced 75.92%	2,305 $27,000
Q1 2022 May 12, 2022	SELL	$6.55 - $17.42 $47,605 - $126,608	-7,268 Reduced 75.92%	2,305 $27,000
Q4 2021 Jun 21, 2023	BUY	$15.51 - $29.31 $116,604 - $220,352	7,518 Added 365.84%	9,573 $155,000
Q3 2021 Jun 21, 2023	BUY	$27.47 - $37.31 $206,519 - $280,496	7,518 Added 365.84%	9,573 $273,000
Q3 2021 Mar 30, 2023	BUY	$27.47 - $37.31 $3,845 - $5,223	140 Added 1.48%	9,573 $273,000
Q3 2021 Nov 15, 2021	BUY	$27.47 - $37.31 $3,845 - $5,223	140 Added 1.48%	9,573 $273,000
Q2 2021 Jun 21, 2023	BUY	$25.45 - $37.64 $187,770 - $277,707	7,378 Added 359.03%	9,433 $318,000
Q2 2021 Mar 30, 2023	BUY	$25.45 - $37.64 $12,012 - $17,766	472 Added 5.27%	9,433 $318,000
Q2 2021 Aug 16, 2021	BUY	$25.45 - $37.64 $239,840 - $354,719	9,424 Added 104711.11%	9,433 $319,000
Q1 2021 Jun 26, 2023	BUY	$29.16 - $51.96 $201,378 - $358,835	6,906 Added 336.06%	8,961 $271 Million
Q1 2021 Mar 30, 2023	SELL	$29.16 - $51.96 $8,835 - $15,743	-303 Reduced 3.27%	8,961 $270,000
Q1 2021 May 14, 2021	SELL	$29.16 - $51.96 $269,875 - $480,889	-9,255 Reduced 99.9%	9 $271,000
Q4 2020 Jun 22, 2023	BUY	$37.86 - $54.26 $272,932 - $391,160	7,209 Added 350.8%	9,264 $458,000
Q3 2020 Jun 26, 2023	BUY	$35.13 - $43.62 $253,252 - $314,456	7,209 Added 350.8%	9,264 $355,000
Q2 2020 Jun 26, 2023	BUY	$23.66 - $49.53 $170,564 - $357,061	7,209 Added 350.8%	9,264 $400,000
Q2 2020 Mar 30, 2023	BUY	$23.66 - $49.53 $46,799 - $97,970	1,978 Added 27.15%	9,264 $400,000
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $46,799 - $97,970	1,978 Added 27.15%	9,264 $400,000
Q1 2020 Jul 12, 2023	BUY	$14.39 - $35.8 $75,274 - $187,269	5,231 Added 254.55%	7,286 $190,000
Q4 2019 Jul 12, 2023	BUY	$23.81 - $33.78 $124,550 - $176,703	5,231 Added 254.55%	7,286 $227,000
Q3 2019 Jul 12, 2023	BUY	$21.57 - $31.37 $112,832 - $164,096	5,231 Added 254.55%	7,286 $189,000
Q3 2019 Mar 30, 2023	BUY	$21.57 - $31.37 $107,699 - $156,630	4,993 Added 217.75%	7,286 $189,000
Q3 2019 Nov 14, 2019	BUY	$21.57 - $31.37 $157,159 - $228,561	7,286 New	7,286 $190,000
Q2 2019 Jul 12, 2023	SELL	$19.51 - $28.31 $9,091 - $13,192	-466 Reduced 22.68%	1,589 $36.3 Million

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

Paradigm Biocapital Advisors LP New York, NY

4.09M
Shares

$45.5 Million
1.93% of portfolio
Black Rock Inc. New York, NY

2.94M
Shares

$32.7 Million
0.0% of portfolio
Sofinnova Investments, Inc. Menlo Park, CA

2.19M
Shares

$24.4 Million
2.73% of portfolio
Vanguard Group Inc Valley Forge, PA

2.04M
Shares

$22.7 Million
0.0% of portfolio
Polar Capital Holdings PLC London, X0

1.83M
Shares

$20.4 Million
0.15% of portfolio

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account